United States Gastroesophageal Reflux Disease Therapeutics Market Report 2017

October 2017 | 104 pages | ID: U8C1AF556AEPEN
QYResearch

Abstracts

In this report, the United States Gastroesophageal Reflux Disease Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Gastroesophageal Reflux Disease Therapeutics in these regions, from 2012 to 2022 (forecast).

United States Gastroesophageal Reflux Disease Therapeutics market competition by top manufacturers/players, with Gastroesophageal Reflux Disease Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca
• Eisai
• Takeda Pharmaceutical
• GlaxoSmithKline
• Johnson & Johnson
• Daewoong Pharmaceutical
• Ironwood Pharmaceuticals
• Rottapharm Madaus
• Peer Medical
• Reviva Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Antacids
• H2 Receptor Blockers
• Proton Pump Inhibitors (PPIs)
• Pro-kinetic Agents
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Gastroesophageal Reflux Disease Therapeutics for each application, including

• Hospital Pharmacy
• Drug Stores
• General Stores
• Supermarkets

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Gastroesophageal Reflux Disease Therapeutics Market Report 2017

1 GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Gastroesophageal Reflux Disease Therapeutics
1.2 Classification of Gastroesophageal Reflux Disease Therapeutics by Product Category
  1.2.1 United States Gastroesophageal Reflux Disease Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Gastroesophageal Reflux Disease Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Antacids
  1.2.4 H2 Receptor Blockers
  1.2.5 Proton Pump Inhibitors (PPIs)
  1.2.6 Pro-kinetic Agents
  1.2.7 Others
1.3 United States Gastroesophageal Reflux Disease Therapeutics Market by Application/End Users
  1.3.1 United States Gastroesophageal Reflux Disease Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacy
  1.3.3 Drug Stores
  1.3.4 General Stores
  1.3.5 Supermarkets
1.4 United States Gastroesophageal Reflux Disease Therapeutics Market by Region
  1.4.1 United States Gastroesophageal Reflux Disease Therapeutics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Gastroesophageal Reflux Disease Therapeutics Status and Prospect (2012-2022)
  1.4.3 Southwest Gastroesophageal Reflux Disease Therapeutics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Gastroesophageal Reflux Disease Therapeutics Status and Prospect (2012-2022)
  1.4.5 New England Gastroesophageal Reflux Disease Therapeutics Status and Prospect (2012-2022)
  1.4.6 The South Gastroesophageal Reflux Disease Therapeutics Status and Prospect (2012-2022)
  1.4.7 The Midwest Gastroesophageal Reflux Disease Therapeutics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Gastroesophageal Reflux Disease Therapeutics (2012-2022)
  1.5.1 United States Gastroesophageal Reflux Disease Therapeutics Sales and Growth Rate (2012-2022)
  1.5.2 United States Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2012-2022)

2 UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Gastroesophageal Reflux Disease Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Gastroesophageal Reflux Disease Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Gastroesophageal Reflux Disease Therapeutics Average Price by Players/Suppliers (2012-2017)
2.4 United States Gastroesophageal Reflux Disease Therapeutics Market Competitive Situation and Trends
  2.4.1 United States Gastroesophageal Reflux Disease Therapeutics Market Concentration Rate
  2.4.2 United States Gastroesophageal Reflux Disease Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Gastroesophageal Reflux Disease Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Gastroesophageal Reflux Disease Therapeutics Sales and Market Share by Region (2012-2017)
3.2 United States Gastroesophageal Reflux Disease Therapeutics Revenue and Market Share by Region (2012-2017)
3.3 United States Gastroesophageal Reflux Disease Therapeutics Price by Region (2012-2017)

4 UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Gastroesophageal Reflux Disease Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Gastroesophageal Reflux Disease Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Gastroesophageal Reflux Disease Therapeutics Price by Type (2012-2017)
4.4 United States Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Gastroesophageal Reflux Disease Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gastroesophageal Reflux Disease Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Eisai
  6.2.2 Gastroesophageal Reflux Disease Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Takeda Pharmaceutical
  6.3.2 Gastroesophageal Reflux Disease Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
  6.4.2 Gastroesophageal Reflux Disease Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Johnson & Johnson
  6.5.2 Gastroesophageal Reflux Disease Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Daewoong Pharmaceutical
  6.6.2 Gastroesophageal Reflux Disease Therapeutics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Ironwood Pharmaceuticals
  6.7.2 Gastroesophageal Reflux Disease Therapeutics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Rottapharm Madaus
  6.8.2 Gastroesophageal Reflux Disease Therapeutics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Peer Medical
  6.9.2 Gastroesophageal Reflux Disease Therapeutics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Peer Medical Gastroesophageal Reflux Disease Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Reviva Pharmaceuticals
  6.10.2 Gastroesophageal Reflux Disease Therapeutics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Gastroesophageal Reflux Disease Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gastroesophageal Reflux Disease Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gastroesophageal Reflux Disease Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gastroesophageal Reflux Disease Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Gastroesophageal Reflux Disease Therapeutics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Gastroesophageal Reflux Disease Therapeutics Sales Volume Forecast by Type (2017-2022)
11.3 United States Gastroesophageal Reflux Disease Therapeutics Sales Volume Forecast by Application (2017-2022)
11.4 United States Gastroesophageal Reflux Disease Therapeutics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gastroesophageal Reflux Disease Therapeutics
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size (K Pcs) by Type (2012-2022)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Antacids Product Picture
Figure H2 Receptor Blockers Product Picture
Figure Proton Pump Inhibitors (PPIs) Product Picture
Figure Pro-kinetic Agents Product Picture
Figure Others Product Picture
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Gastroesophageal Reflux Disease Therapeutics by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Drug Stores Examples
Table Key Downstream Customer in Drug Stores
Figure General Stores Examples
Table Key Downstream Customer in General Stores
Figure Supermarkets Examples
Table Key Downstream Customer in Supermarkets
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure The West Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Gastroesophageal Reflux Disease Therapeutics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Gastroesophageal Reflux Disease Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Gastroesophageal Reflux Disease Therapeutics Sales Share by Players/Suppliers
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Gastroesophageal Reflux Disease Therapeutics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Gastroesophageal Reflux Disease Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Gastroesophageal Reflux Disease Therapeutics Revenue Share by Players/Suppliers
Table United States Market Gastroesophageal Reflux Disease Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Gastroesophageal Reflux Disease Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Gastroesophageal Reflux Disease Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Gastroesophageal Reflux Disease Therapeutics Product Category
Table United States Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs) by Region (2012-2017)
Table United States Gastroesophageal Reflux Disease Therapeutics Sales Share by Region (2012-2017)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Share by Region (2012-2017)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Region in 2016
Table United States Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Gastroesophageal Reflux Disease Therapeutics Revenue Share by Region (2012-2017)
Figure United States Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Region (2012-2017)
Figure United States Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Region in 2016
Table United States Gastroesophageal Reflux Disease Therapeutics Price (USD/Pcs) by Region (2012-2017)
Table United States Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs) by Type (2012-2017)
Table United States Gastroesophageal Reflux Disease Therapeutics Sales Share by Type (2012-2017)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Share by Type (2012-2017)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Type in 2016
Table United States Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Gastroesophageal Reflux Disease Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastroesophageal Reflux Disease Therapeutics by Type (2012-2017)
Figure Revenue Market Share of Gastroesophageal Reflux Disease Therapeutics by Type in 2016
Table United States Gastroesophageal Reflux Disease Therapeutics Price (USD/Pcs) by Types (2012-2017)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs) by Application (2012-2017)
Table United States Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Market Share by Application in 2016
Table United States Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate (2012-2017)
Figure AstraZeneca Gastroesophageal Reflux Disease Therapeutics Sales Market Share in United States (2012-2017)
Figure AstraZeneca Gastroesophageal Reflux Disease Therapeutics Revenue Market Share in United States (2012-2017)
Table Eisai Basic Information List
Table Eisai Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eisai Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate (2012-2017)
Figure Eisai Gastroesophageal Reflux Disease Therapeutics Sales Market Share in United States (2012-2017)
Figure Eisai Gastroesophageal Reflux Disease Therapeutics Revenue Market Share in United States (2012-2017)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Sales Market Share in United States (2012-2017)
Figure Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Revenue Market Share in United States (2012-2017)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate (2012-2017)
Figure Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Sales Market Share in United States (2012-2017)
Figure Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue Market Share in United States (2012-2017)
Table Ironwood Pharmaceuticals Basic Information List
Table Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate (2012-2017)
Figure Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Sales Market Share in United States (2012-2017)
Figure Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue Market Share in United States (2012-2017)
Table Rottapharm Madaus Basic Information List
Table Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate (2012-2017)
Figure Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Sales Market Share in United States (2012-2017)
Figure Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Revenue Market Share in United States (2012-2017)
Table Peer Medical Basic Information List
Table Peer Medical Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Peer Medical Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate (2012-2017)
Figure Peer Medical Gastroesophageal Reflux Disease Therapeutics Sales Market Share in United States (2012-2017)
Figure Peer Medical Gastroesophageal Reflux Disease Therapeutics Revenue Market Share in United States (2012-2017)
Table Reviva Pharmaceuticals Basic Information List
Table Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Sales Growth Rate (2012-2017)
Figure Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Sales Market Share in United States (2012-2017)
Figure Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastroesophageal Reflux Disease Therapeutics
Figure Manufacturing Process Analysis of Gastroesophageal Reflux Disease Therapeutics
Figure Gastroesophageal Reflux Disease Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Gastroesophageal Reflux Disease Therapeutics Major Players/Suppliers in 2016
Table Major Buyers of Gastroesophageal Reflux Disease Therapeutics
Table Distributors/Traders List
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Gastroesophageal Reflux Disease Therapeutics Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Gastroesophageal Reflux Disease Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Gastroesophageal Reflux Disease Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Gastroesophageal Reflux Disease Therapeutics Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Gastroesophageal Reflux Disease Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Gastroesophageal Reflux Disease Therapeutics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources